Dapagliflozin + Sitagliptin

Fixed-dose combination

This page lists brands whose active-ingredient set is exactly the combination below. It is identity information only — a fixed-dose combination is not the same product as its single ingredients, and the brand names are not interchangeable across markets.

Not medical advice. Check the pack and the exact composition before comparing products; ask a pharmacist if unsure.

Active ingredients

Brands with this exact combination

BrandComposition & strengthManufacturer
DAGRAFORS DUOCZ
  • tablet ×30 Dapagliflozin 12.3 mg + Sitagliptin 128.48 mg
Krka, d.d., Novo mesto, Novo mesto
DIBAGLEPCZ
  • tablet ×9 Dapagliflozin 10 mg + Sitagliptin 113.38 mg
VIATRIS LIMITED, Dublin
OPVENTICZ LV
  • tablet ×2 Dapagliflozin 10 mg + Sitagliptin 113.38 mg
  • tablet Dapagliflozin 10 mg + Sitagliptin 100 mg
Egis Pharmaceuticals PLC, Budapešť
Dapagliflozin + sitagliptinAU10 mg / 100 mgAstraZeneca Pty Ltd
Daplussi 100 mg/10 mg apvalkotās tabletesLV
  • tablet Dapagliflozin 10 mg + Sitagliptin 100 mg
KRKA, d.d., Novo mesto, Slovenia
Daplussi 100 mg/10 mg film-coated tabletsLV
  • tablet Dapagliflozin 10 mg + Sitagliptin 100 mg
KRKA, d.d., Novo mesto, Slovenia
Opventi 100 mg/10 mg apvalkotās tabletesLV
  • tablet Dapagliflozin 10 mg + Sitagliptin 100 mg
Egis Pharmaceuticals PLC, Hungary
Sitagliptin/Dapagliflozin Teva 100 mg/10 mg apvalkotās tabletesLV
  • tablet Dapagliflozin 10 mg + Sitagliptin 100 mg
Teva B.V., Netherlands
Sitagliptin/Dapagliflozin Teva 100 mg/10 mg film-coated tabletsLV
  • tablet Dapagliflozin 10 mg + Sitagliptin 100 mg
Teva B.V., Netherlands

Same combination in other markets

These markets record products with the same active-ingredient combination. Identity only — not a recommendation that products are interchangeable.

See warnings for these ingredients

Source & licence: built from the same regulator data as the ingredient pages (openFDA, dm+d, CIMA, COFEPRIS, PBS/TGA, Health Canada DPD, NHSA). Facts only; see the licence register.